% Exported from Psilocybin Research Publication Tracker
% Tracker site: https://psilocybin-research.com
% Publication tracker: https://psilocybin-research.com/
\documentclass[11pt]{article}
\usepackage[T1]{fontenc}
\usepackage[utf8]{inputenc}
\usepackage{enumitem}
\usepackage[hidelinks]{hyperref}
\usepackage[margin=1in]{geometry}
\title{Psilocybin and Psilocin Research Export}
\author{Psilocybin Research Publication Tracker}
\date{2026-07-09}
\begin{document}
\maketitle
\noindent Exported from \href{https://psilocybin-research.com}{psilocybin-research.com}. Records: 34.

\begin{enumerate}[leftmargin=*]
\item Damian Świeczkowski, Aleksander Kwaśny, Krzysztof Sadko, Wiesław Jerzy Cubała (2026). \textit{Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2025.112746}{doi:10.1016/j.euroneuro.2025.112746}.
\item M. Nikolič, Vojtěch Viktorin, Peter Zach, Filip Tylš, Daniela Dudysová, Karolína Janků, Jana Kopřivová, Martin Kuchař, Martin Brunovský, Jiřı́ Horáček, Tomáš Páleníček (2023). \textit{Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2023.04.019}{doi:10.1016/j.euroneuro.2023.04.019}.
\item Drummond E-Wen McCulloch, M. Madsen, Dea Siggaard Stenbæk, Søren Kristiansen, Brice Ozenne, P.S. Jensen, Gitte M. Knudsen, Patrick M. Fisher (2021). \textit{P.0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.557}{doi:10.1016/j.euroneuro.2021.10.557}.
\item Hannah Douglass, Meg J. Spriggs, R.J. Park, Tim Read, Jennifer L. Danby, Frederico José Coelho de Magalhães, Kirsty L. Alderton, Adèle Lafrance, Dasha Nicholls, David Erritzøe, David Nutt, Robin Carhart-Harris (2021). \textit{P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.335}{doi:10.1016/j.euroneuro.2021.10.335}.
\item Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Max Wolff, Andreas Ströhle, Stefan Wellek, Gerhard Gründer (2021). \textit{P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.394}{doi:10.1016/j.euroneuro.2021.10.394}.
\item Dea Siggaard Stenbæk, M. Madsen, Sophia Armand, Catharina Messel, Maria Zofia Grzywacz, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2021). \textit{P.0828 Psilocybin enhances emotional response to music in healthy individuals}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.687}{doi:10.1016/j.euroneuro.2021.10.687}.
\item Ines Erkizia-Santamaría, R. Alles-Pascual, Igor Horrillo, J. Javier Meana, Jorge E. Ortega (2021). \textit{P.0298 Evaluation of the acute mechanism of action of psilocybin in mice}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.282}{doi:10.1016/j.euroneuro.2021.10.282}.
\item A. Andreiev, E. Bucuci, James Chue, Charl Els, Pierre Chue (2021). \textit{P.0623 The clinical relevance of the pharmacokinetics of psilocybin}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.588}{doi:10.1016/j.euroneuro.2021.10.588}.
\item Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt, Robin Carhart-Harris (2021). \textit{P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.741}{doi:10.1016/j.euroneuro.2021.10.741}.
\item Sara Penedos, Caio Freitas Ramos, María José López Miguel, Márcio José Martins Alves, Luciana Campos Paulino, Adriano Valério S. Azevêdo, M. Magalhães, L. Moreno, N. Ribeiro, Inês Fonseca, Ana Margarida Romão Franco, Luís Madruga, A. Gamito (2021). \textit{P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature review}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.797}{doi:10.1016/j.euroneuro.2021.10.797}.
\item Olejníková L., Danda H., Lhotková E., Kútná V., Šíchová K., Syrová K., Mazochová K., Páleníček T. (2021). \textit{P.0553 Effect of chronic microdosing of psilocin on cell proliferation and behavior in rats}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.523}{doi:10.1016/j.euroneuro.2021.10.523}.
\item Vejmola Č., Syrová K., Koudelka V., Šíchová K., Tesař M., Dodoková A., Kelemen E., Páleníček T. (2021). \textit{P.0858 Psilocin induces perceptual alterations in rats: visual discrimination study}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/j.euroneuro.2021.10.715}{doi:10.1016/j.euroneuro.2021.10.715}.
\item Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM. (2021). \textit{Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.}. European Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2021.06.001}{doi:10.1016/j.euroneuro.2021.06.001}.
\item Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, Felix Müller, Johannes G. Ramaekers (2021). \textit{P.214 (Sub)acute effects of psilocybin on creative cognition: a double-blind, placebo-controlled experimental study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2021.01.043}{doi:10.1016/j.euroneuro.2021.01.043}.
\item Lene Lundgaard Donovan, Jens Vilstrup Johansen, Nídia Fernandez Ros, Elham Jaberi, Kristían Línnet, Sys Stybe Johansen, Brice Ozenne, Shohreh Issazadeh-Navikas, Hanne D. Hansen, Gitte M. Knudsen (2020). \textit{Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.11.013}{doi:10.1016/j.euroneuro.2020.11.013}.
\item Nakul Ravi Raval, Annette Johansen, Lene Lundgaard Donovan, Nelson Ros, Brice Ozenne, Hanne D. Hansen, Gitte M. Knudsen (2020). \textit{P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.09.589}{doi:10.1016/j.euroneuro.2020.09.589}.
\item M. Madsen, Dea Siggaard Stenbæk, Brice Ozenne, Sophia Armand, M.R. Marstrand-Jørgensen, Albin Arvidsson, Sys Stybe Johansen, Kristían Línnet, Gitte M. Knudsen, Patrick M. Fisher (2020). \textit{P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experience}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.09.169}{doi:10.1016/j.euroneuro.2020.09.169}.
\item M. Madsen, Patrick M. Fisher, Dea Siggaard Stenbæk, Sara Kristiansen, Daniel Burmester, Szabolcs Lehel, Tomáš Páleníček, Martin Kuchař, Claus Svarer, Brice Ozenne, Gitte M. Knudsen (2020). \textit{A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2020.02.001}{doi:10.1016/j.euroneuro.2020.02.001}.
\item Natasha L. Mason, Kim P. C. Kuypers, Johannes T. Reckweg, Desmond H. Y. Tse, Felix Müller, Stefan W. Toennes, Amanda Feilding, Johannes G. Ramaekers (2020). \textit{P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective state}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.12.087}{doi:10.1016/j.euroneuro.2019.12.087}.
\item K. Kiilerich, Nikolaj Speth, J. Lorenz, Agata Casado-Sainz, Vladimir Shalgunov, Denise Lange, Mengfei Xiong, Matthias M. Herth, Agnete Overgaard, Hanne D. Hansen, Mikael Palner (2019). \textit{P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low doses}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.271}{doi:10.1016/j.euroneuro.2019.09.271}.
\item Mie Madsen, P.M. Fisher, D.S. Stenbæk, S. Kristiansen, D. Burmester, S. Lehel, Tomáš Páleníček, Claus Svarer, B. Ozenne, Gitte M. Knudsen (2019). \textit{P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.232}{doi:10.1016/j.euroneuro.2019.09.232}.
\item Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris (2019). \textit{P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.593}{doi:10.1016/j.euroneuro.2019.09.593}.
\item Dea Siggaard Stenbæk, M.K. Madsen, Brice Ozenne, Søren Kristiansen, Daniel Burmester, David Erritzøe, Gitte M. Knudsen, Patrick M. Fisher (2019). \textit{P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2019.09.702}{doi:10.1016/j.euroneuro.2019.09.702}.
\item P. Dürler (2018). \textit{Psilocybin induces aberrant prediction error processing for tactile mismatch responses}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.477}{doi:10.1016/j.euroneuro.2018.11.477}.
\item M. Madsen, Daniel Burmester, Dea Siggaard Stenbæk, Søren Kristiansen, Agnete Dyssegaard, Szabolcs Lehel, Kristían Línnet, Sys Stybe Johansen, Claus Svarer, Brice Ozenne, David Erritzøe, Patrick M. Fisher, Gitte M. Knudsen (2018). \textit{Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/j.euroneuro.2018.11.474}{doi:10.1016/j.euroneuro.2018.11.474}.
\item Grimm O, Kraehenmann R, Preller KH, Seifritz E, Vollenweider FX. (2018). \textit{Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.}. European Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2018.03.016}{doi:10.1016/j.euroneuro.2018.03.016}.
\item Filip Tylš, Čestmír Vejmola, Michaela Viktorinová, L. Kadeřábek, Tomáš Páleníček (2016). \textit{Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(16)31133-6}{doi:10.1016/s0924-977x(16)31133-6}.
\item O. Grimm, Rainer Krähenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider (2016). \textit{Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination task}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(16)31070-7}{doi:10.1016/s0924-977x(16)31070-7}.
\item Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX. (2016). \textit{Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.}. European Neuropsychopharmacology. [published; Europe PMC]. \href{https://doi.org/10.1016/j.euroneuro.2016.01.005}{doi:10.1016/j.euroneuro.2016.01.005}.
\item Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider (2015). \textit{P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(15)30364-3}{doi:10.1016/s0924-977x(15)30364-3}.
\item Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider (2014). \textit{P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(14)70316-5}{doi:10.1016/s0924-977x(14)70316-5}.
\item Tyls F., Palenicek T., Novakova P., Kaderabek L., Fujakova M., Kubesova A., Horacek J. (2014). \textit{P.4.022 The impact of serotonin system modulation on behavior and quantitative EEG in an animal model of psychosis induced by psilocin}. European Neuropsychopharmacology. [published; Crossref]. \href{https://doi.org/10.1016/s0924-977x(14)70111-7}{doi:10.1016/s0924-977x(14)70111-7}.
\item Robin Carhart-Harris, David Erritzøe, James Stone, Rjs Wise, David Nutt (2011). \textit{P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(11)70495-3}{doi:10.1016/s0924-977x(11)70495-3}.
\item Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider (2003). \textit{P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis}. European Neuropsychopharmacology. [published; OpenAlex]. \href{https://doi.org/10.1016/s0924-977x(03)92355-8}{doi:10.1016/s0924-977x(03)92355-8}.
\end{enumerate}
\end{document}
